BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Östbye H, Gao J, Martinez MR, Wang H, de Gier JW, Daniels R. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication. J Virol 2020;94:e00874-20. [PMID: 32699088 DOI: 10.1128/JVI.00874-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 López-Valiñas Á, Sisteré-Oró M, López-Serrano S, Baioni L, Darji A, Chiapponi C, Segalés J, Ganges L, Núñez JI. Identification and Characterization of Swine Influenza Virus H1N1 Variants Generated in Vaccinated and Nonvaccinated, Challenged Pigs. Viruses 2021;13:2087. [PMID: 34696517 DOI: 10.3390/v13102087] [Reference Citation Analysis]
2 Creytens S, Pascha MN, Ballegeer M, Saelens X, de Haan CAM. Influenza Neuraminidase Characteristics and Potential as a Vaccine Target. Front Immunol 2021;12:786617. [PMID: 34868073 DOI: 10.3389/fimmu.2021.786617] [Reference Citation Analysis]
3 Alymova IV, Cipollo JF, Parsons LM, Music N, Kamal RP, Tzeng W, Goldsmith CS, Contessa JN, Hartshorn KL, Wilson JR, Zeng H, Gansebom S, York IA, Subbarao K. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome. mBio. [DOI: 10.1128/mbio.02983-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao J, Klenow L, Parsons L, Malik T, Phue JN, Gao Z, Withers SG, Cipollo J, Daniels R, Wan H. Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy. J Virol 2021;95:e0116021. [PMID: 34613807 DOI: 10.1128/JVI.01160-21] [Reference Citation Analysis]
5 Gao J, Wan H, Li X, Rakic Martinez M, Klenow L, Gao Y, Ye Z, Daniels R. Balancing the influenza neuraminidase and hemagglutinin responses by exchanging the vaccine virus backbone. PLoS Pathog 2021;17:e1009171. [PMID: 33872324 DOI: 10.1371/journal.ppat.1009171] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Campbell AC, Tanner JJ, Krause KL. Optimisation of Neuraminidase Expression for Use in Drug Discovery by Using HEK293-6E Cells. Viruses 2021;13:1893. [PMID: 34696326 DOI: 10.3390/v13101893] [Reference Citation Analysis]
7 Luo R, Delaunay-Moisan A, Timmis K, Danchin A. SARS-CoV-2 biology and variants: anticipation of viral evolution and what needs to be done. Environ Microbiol 2021;23:2339-63. [PMID: 33769683 DOI: 10.1111/1462-2920.15487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]